This test is most useful if any of these apply to you.
When a serious infection takes hold, your bone marrow does something visible on an ordinary blood count: it starts releasing white cells before they've finished maturing. IG% (immature granulocyte percentage) is the share of your circulating white cells that are these early releases. In healthy people it sits near zero, so a rise usually means something is pushing your marrow, most often infection or inflammation.
This number comes with most modern blood counts at no extra cost. In hospital studies it flagged infection somewhat better than the total white cell count, but it missed too many cases to work as a standalone infection test. It hasn't been tested as a screening tool in healthy adults, and labs don't share one standard cutoff, so it's most useful as one part of a pattern you track over time.
Granulocytes are the most common type of white blood cell. Most of them are neutrophils, the cells that arrive first when bacteria get in. They're built in the bone marrow through several stages, and the early, unfinished stages normally stay inside the marrow until they're ready.
When infection, inflammation, trauma, or a bone marrow disorder creates a sudden demand, the marrow speeds up production and pushes some unfinished cells out early. Researchers call this emergency production. IG% tells you what fraction of your white cells are these early releases, so it reflects how hard your marrow is being pushed.
Most labs count these cells automatically on the same analyzer that runs your blood count, which is more reproducible than a technician counting cells by eye. Different analyzer brands detect these cells in different ways and report somewhat different numbers, though, which matters when you compare results from two labs.
Sepsis happens when the body's response to an infection starts damaging its own organs. It's where this number has been studied most, and the pattern is consistent: people with infections, bacteria in the blood, or sepsis tend to have a higher share of young white cells than people without them, and higher values go with more severe illness and higher death rates.
Three hospital studies give a sense of how well it performs against tests you may already know.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 117 adults in a burn unit | Share of young white cells in people who did and did not develop sepsis | Picked up about three in four sepsis cases and correctly cleared about two in three people without it |
| 154 hospital patients tested for infection | Share of young white cells versus the total white cell count | Predicted infection better than the total count and about as well as the neutrophil count, but missed too many cases to work as a screening test on its own |
| Adults in intensive care | Share of young white cells versus C-reactive protein, a standard inflammation test | Predicted infection about as well as the inflammation test, and adding it helped rule infection out early |
Source: Jeon et al. (burn unit); Ansari-Lari et al. (hospital patients); van der Geest et al. (intensive care).
What this means for you: a single elevated reading is a reason to look for an infection, and it isn't proof of one. Its accuracy in these studies was moderate, so it supports a diagnosis rather than making one. The rule-out finding comes from intensive care, where a low value alongside other tests helped exclude infection early. It hasn't been tested in people outside the hospital, so treat a low reading next to a normal white count and inflammation test as reassuring context, not a guarantee.
The number also moves with treatment. In 87 people treated for sepsis, those whose share of young cells was still high on the third day were more likely to have treatment fail and to die. In 196 people with sepsis who received a blood-filtering therapy, young white cell levels fell along with other inflammation markers, and how the levels moved afterward tracked who survived.
Acute pancreatitis is sudden inflammation of the pancreas, and it ranges from a few miserable days to a life-threatening illness. In a study of 1,933 people with it, a higher share of young white cells helped pick out early who would go on to develop severe lung failure. In another 218 people, higher values went with more severe disease and with death in the hospital, and the highest readings were uncommon among people who survived, so very high values may be a stronger warning than modest ones.
Appendicitis is less clear. In 403 adults who came to an emergency room with suspected appendicitis, the percentage barely separated those who had it from those who didn't. A smaller study of 140 people found the absolute count of young cells more useful than the percentage for spotting complicated, more advanced cases.
In 149 people hospitalized for bleeding in the upper digestive tract, a high share of young white cells predicted death in the hospital. Each finding in this section rests on a single study, mostly looking back at hospital records, and none has been confirmed widely enough to set a cutoff that guides treatment.
Cirrhosis is advanced scarring of the liver. In 210 people with cirrhosis whose liver had already started to fail, a higher share of young white cells was linked to a higher risk of dying or needing a transplant, and the link held after accounting for other risk factors. This is one study and still needs confirmation in other groups.
If you're living with cirrhosis, this number is already on your blood count. A rise across successive draws is worth asking about, starting with whether an infection is brewing.
In 78 people who came to an emergency department with a heart attack or unstable chest pain, a higher share of young white cells went along with more extensive and complex blockages in the heart's arteries. It was one small study that measured blockages at a single point in time, so it shows a link with how much disease was present and says nothing yet about predicting who will have a heart attack.
The same signal shows up more faintly in conditions without an acute infection. Children with chronic kidney disease who had more inflammation had higher values. In a study of 158 people, those with fibromyalgia had higher values than healthy controls, which the authors read as a sign of low-level inflammation in at least some of them.
In 311 women going through in vitro fertilization, a lower share of young white cells went with higher rates of pregnancy and live birth. That fits the broader picture, where lower values tend to mean a calmer immune background, though these are associations from single studies.
Newborns run much higher values than adults in the first days of life, and adult or child norms over-call infection in them. In one study of 199 newborns on a specific analyzer, infected babies had a lower automated count of young cells, the opposite of the adult pattern, while a much larger newborn study found automated and manual counts about equally useful for spotting infection.
Those findings fit together once you treat the number as context-dependent. In adults and older children, a rise means the marrow is releasing cells early. In newborns, the baseline is different and the machine's count can behave differently depending on the analyzer, so the adult reading of the number doesn't carry over. If you're an adult reading your own result, the adult pattern applies.
Usually it doesn't. In about 2,400 outpatients, the most common reason for an elevated value in children was infection. In adults the list was broader: blood cancers, medications, severe infections, and pregnancy.
Because blood cancers are on that list, a persistent elevation with no obvious explanation deserves follow-up. When a blood cancer is the cause, the lab usually sees more than this one number out of place, and a blood smear reviewed under a microscope is the standard next step.
The most common way to misread this number is to test while your body is dealing with something temporary. A few other factors shift it without telling you anything about your usual state.
As with any automated count, unusual sample problems can occasionally affect the result, which is one more reason a surprising value should be repeated before you act on it.
Because this number reacts to whatever your immune system is handling that week, one reading mostly describes that week. The sepsis studies make the case for trends: the course over the following days, falling in people who recovered and staying high in those who didn't, carried the information about outcome.
Get a baseline on a day you feel well. Retest in 3 to 6 months if you're managing an inflammatory condition or recovering from an illness, then at least once a year, ideally at the same lab. If a value comes back high during or right after an infection, repeat it once you've recovered to confirm it came back down.
What a high value should prompt depends on what else is going on. Treat it as one piece of a pattern and read it next to your total white count, neutrophil count, and an inflammation test such as high-sensitivity C-reactive protein.
A low or zero value in an adult who feels well is the common, expected result. It becomes useful as your reference point the next time you're sick or the number changes.
Evidence-backed interventions that affect your Immature Granulocyte % level
Immature Granulocyte % is best interpreted alongside these tests.